Physician Scientist studying cancer immunotherapy-IrAEs and thyroid cancer. Onco-Endocrinology Program @UCLA.
Joined July 2021
- Tweets31
- Following31
- Followers115
- Likes5
Congratulations to Kyleigh Kimbrell for her recognition at the 2025 ATA meeting for research excellence in thyroid autoimmunity and sex differences! This is a crucial area of study that needs more attention. wix.to/CRrSXo0 #WomenInSTEM @AmThyroidAssn @UCLAHealth
ENDO 2025 - Excited to collaborate with UCSF, USC, U Colorado, and UNC Chapel Hill on our multi-center trial aiming to tackle ICI-Diabetes. Innovation in cancer treatment is our goal! Read more: wix.to/M8Grg8F #CancerResearch #ICI
New research alert! We explore strategies to reverse checkpoint inhibitor diabetes in our latest publication. Insights on autoimmune side effects from cancer treatments await you! Check it out: wix.to/AEKj4c4 #uclaitox #CancerResearch #Diabetes
Trump hits NIH with ‘devastating’ freezes on meetings, travel, communications, and hiring | Science | AAAS science.org/content/article/…
UCLA is now an NIH Autoimmune Center of Excellence. This represents a significant milestone in our dedication to innovative research in autoimmunity and excited to be a part of this group. wix.to/UaWTWMh #UCLA #Autoimmunity
We are shutting down the labs and many are displaced. Grateful for our colleagues and friends during this challenging time at UCLA. 💙 wix.to/4Au3fAB
New research on IrAE mechanisms and risk factors at the 2024 SITC meeting, wix.to/MRpJGem
Jarod, Kyleigh, and Jaden excel at ATA Chicago 2024
@amos18 @AmThyroidAssn @UCLAHealth
wix.to/4F8dAvv
Increased IRAEs in Breast Cancer Patients Treated with RANKL inhibitor Denosumab + Checkpoint Inhibitor - Podium talk at San Antonio Breast Cancer Symposium by Dr. LeVee @UCLA @AlexisLeVee @ Cityofhope @SABCSSanAntonio
wix.to/e7qmcW5
Congratulations to Sarah and Nicole - Uncovering the pathogenesis and potential therapy for ICI-Diabetes at Endo Society this week.#Endo2024
wix.to/8rciuVB
Su-Lechner labs happy to be on winter break!
wix.to/ykyAwCq
Can't wait to read this - always insightful work from the Landa Lab
Our manuscript "Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes" is now available at @CCR_AACR
A thread [1/15]
aacrjournals.org/clincancerr…
Shedding new light on the dark side of cancer immunotherapy - mechanisms of IRAEs. Just out in @ScienceTM, grateful for support from @UCLAHealth and @AmThyroidAssn and my collaborators @DoctorAngell @MaureenSuLab wix.to/yPSqMbG
Melissa G. Lechner, MD, PhD retweeted
1/25. Our work out in @JCO_ASCO! Real-world report from the CATCH-IT consortium. Fortunate to share this journey w/ co-authors, co-first authors @adib_Elio, @TalalZarif1 and under the mentorship of #naqashlab @sonpavde! @YaleCancer, @DanaFarberNews@YaleIMed. Tweetorial below:
Tackling checkpoint inhibitor endocrine autoimmune toxicities with great colleagues at the @fredhutch -
youtube.com/watch?v=8U3eBlsk…
Check it out from Dr. Willy Hugo @UCLA New insights into anti-PD1 response in melanoma: Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors biorxiv.org/content/10.1101/…
Great to see my dear medical school friend @AlexisEDixonMD being awesome! Wouldn’t trust anyone else with my precious runner feet. laweekly.com/the-heal-instit…
Enjoyed speaking about immunology with Jatin and Eugenio of @AntibuddiesP this week - check out their other episodes immunology and human disease, too!
xitter.cf/AntibuddiesP/status/15…
We sat down with Dr. Melissa Lechner (@MelissaGLechner) from the UCLA David Geffen School of Medicine to discuss her recent paper about the mechanisms behind immune checkpoint inhibitor-induced autoimmune thyroiditis. Check out the discussion here.
open.spotify.com/episode/5rW…